A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

Part of paid clinical trials in Seattle, Washington.

Sponsor
Fred Hutchinson Cancer Center
Study ID
NCT06909500
Status
Recruiting
Apply to this trial

Conditions

  • Nicotine Dependence
  • Tobacco-Related Carcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - 30 Years
Healthy Volunteers
Accepted

Interventions

  • Smartphone app — BEHAVIORAL
    Receive access to the ACT on Vaping app
  • Smartphone app — BEHAVIORAL
    Receive access to the ACT on Vaping app
  • Text Message — OTHER
    Receive incentivized text messages to access vaping status
  • Text Message — OTHER
    Receive intervention text messages
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.

Key Dates

Start date
Jun 15, 2026
Status verified
May 2026
Primary completion
Nov 15, 2027
Completion
Nov 15, 2027

Study Design

Enrollment
1,178 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Arm I (ACT on Vaping app (Version A) + incentivized texts + intervention texts)
    Participants receive access to the ACT on Vaping app utilizing Acceptance and Commitment Therapy. Participants also receive text message intervention content, as well as incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess changes in vaping on study.
  • Sham Comparator: Arm II (ACT on Vaping app (Version B) + incentivized texts)
    Participants receive access to the ACT on Vaping app including health education content. Participants receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess changes in vaping on study.

Primary Outcome Measure

Cotinine-confirmed 30-day point prevalence abstinence from all nicotine and tobacco [ Time Frame: At 6 months post-randomization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Fred Hutch/University of Washington Cancer ConsortiumSeattleWashington98109
Jaimee Heffner, PhD
[email protected]
206-667-7314
Jaimee Heffner, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Seattle, WA

By research site
Fred Hutch/University of Washington Cancer Consortium· Seattle, WA

Related Studies